Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon. We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 10; no. 11; p. e0142164
Main Authors Hasegawa, Satoru, Goto, Sae, Tsuji, Hirokazu, Okuno, Tatsuya, Asahara, Takashi, Nomoto, Koji, Shibata, Akihide, Fujisawa, Yoshiro, Minato, Tomomi, Okamoto, Akira, Ohno, Kinji, Hirayama, Masaaki
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 05.11.2015
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon. We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
AbstractList The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon.We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing.In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD.The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
Background The intestine is one of the first affected organs in Parkinson’s disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon. Methods We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. Results In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. Conclusions The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon. We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
BACKGROUNDThe intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon.METHODSWe recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing.RESULTSIn PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD.CONCLUSIONSThe permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
Background The intestine is one of the first affected organs in Parkinson’s disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the colon. Methods We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. Results In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)-binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. Conclusions The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.
Author Shibata, Akihide
Minato, Tomomi
Asahara, Takashi
Ohno, Kinji
Hasegawa, Satoru
Goto, Sae
Okuno, Tatsuya
Nomoto, Koji
Hirayama, Masaaki
Okamoto, Akira
Tsuji, Hirokazu
Fujisawa, Yoshiro
AuthorAffiliation 3 Yakult Central Institute, Tokyo, Japan
1 Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, GERMANY
4 Department of School Health Sciences, Aichi University of Education, Kariya, Japan
2 Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
AuthorAffiliation_xml – name: 2 Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
– name: 4 Department of School Health Sciences, Aichi University of Education, Kariya, Japan
– name: 3 Yakult Central Institute, Tokyo, Japan
– name: 1 Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
– name: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, GERMANY
Author_xml – sequence: 1
  givenname: Satoru
  surname: Hasegawa
  fullname: Hasegawa, Satoru
– sequence: 2
  givenname: Sae
  surname: Goto
  fullname: Goto, Sae
– sequence: 3
  givenname: Hirokazu
  surname: Tsuji
  fullname: Tsuji, Hirokazu
– sequence: 4
  givenname: Tatsuya
  surname: Okuno
  fullname: Okuno, Tatsuya
– sequence: 5
  givenname: Takashi
  surname: Asahara
  fullname: Asahara, Takashi
– sequence: 6
  givenname: Koji
  surname: Nomoto
  fullname: Nomoto, Koji
– sequence: 7
  givenname: Akihide
  surname: Shibata
  fullname: Shibata, Akihide
– sequence: 8
  givenname: Yoshiro
  surname: Fujisawa
  fullname: Fujisawa, Yoshiro
– sequence: 9
  givenname: Tomomi
  surname: Minato
  fullname: Minato, Tomomi
– sequence: 10
  givenname: Akira
  surname: Okamoto
  fullname: Okamoto, Akira
– sequence: 11
  givenname: Kinji
  surname: Ohno
  fullname: Ohno, Kinji
– sequence: 12
  givenname: Masaaki
  surname: Hirayama
  fullname: Hirayama, Masaaki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26539989$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9uFCEUxompse3qGxidxJvezAoDzDBemGjrn002sYl6Tc4As2WdhRFmbPbO1_D1fBLZ7qxpGyMhgRx-5-ODc07RkfPOIPSU4DmhFXm59mNw0M37FJ5jwgpSsgfohNS0yMsC06Nb-2N0GuMaY05FWT5Cx0XJaV2L-gQ1CzeYONiklF1sY2N9tDEDp7OlvzbB6OyzCeMmW9re977bRlDqCoLVJn9rnbZulV0GPxjrsjQvIXyzLnr3--evmF3YaCCax-hhC100T6Z1hr6-f_fl_GO-_PRhcf5mmSteF0MuKtwCwxVRaWiKQasKN4a3ZatrXVVQaGYwtJQR3hBe0UJgzbmhRWs4p5zO0PO9bt_5KKfviZJUFJeCYYoTsdgT2sNa9sFuIGylBytvAj6sJITBqs5IwTSpMBiteMuUbhragNANK6GoKRV10no93TY2m4QZNwTo7ojePXH2Sq78D8lKykSyP0Nnk0Dw38dUA7mxUZmuA2f8eOObVIKKgiT0xT303697dtvRXyuHYifg1R5QwccYTCuVHWCwfmfQdpJgueusg7jcdZacOisls3vJB_3_pv0But_YcA
CitedBy_id crossref_primary_10_1007_s10096_020_03944_2
crossref_primary_10_1186_s12915_020_00775_7
crossref_primary_10_1016_j_brainresbull_2019_07_027
crossref_primary_10_1016_j_micpath_2020_104675
crossref_primary_10_1002_pro_4137
crossref_primary_10_3390_ijms25147741
crossref_primary_10_1007_s00115_020_01011_x
crossref_primary_10_1016_j_brainres_2017_04_019
crossref_primary_10_1016_j_biopha_2023_114816
crossref_primary_10_1186_s12974_022_02510_1
crossref_primary_10_1016_j_cell_2016_11_018
crossref_primary_10_3233_JPD_191711
crossref_primary_10_1016_j_nbd_2019_02_011
crossref_primary_10_1371_journal_pone_0223238
crossref_primary_10_1080_21688370_2018_1425085
crossref_primary_10_3233_JPD_181477
crossref_primary_10_3390_nu13030732
crossref_primary_10_1111_hepr_13001
crossref_primary_10_3389_fmicb_2017_01388
crossref_primary_10_1016_S2468_1253_22_00241_2
crossref_primary_10_1007_s00401_017_1777_8
crossref_primary_10_56082_annalsarscibio_2020_1_45
crossref_primary_10_1007_s10571_023_01319_7
crossref_primary_10_1590_1516_4446_2020_0987
crossref_primary_10_1111_lam_13333
crossref_primary_10_1134_S0006297924030118
crossref_primary_10_2478_ahem_2021_0021
crossref_primary_10_1371_journal_pone_0258226
crossref_primary_10_3390_microorganisms12020325
crossref_primary_10_3390_nu16030342
crossref_primary_10_1007_s12223_022_00977_2
crossref_primary_10_3390_cells8030222
crossref_primary_10_1016_j_phrs_2023_106787
crossref_primary_10_3389_fnins_2021_708587
crossref_primary_10_3390_jcm10071392
crossref_primary_10_4103_2045_9912_344977
crossref_primary_10_1038_s41531_021_00170_1
crossref_primary_10_1016_j_bpg_2017_09_009
crossref_primary_10_1007_s13760_023_02195_0
crossref_primary_10_1016_j_neurol_2022_12_010
crossref_primary_10_3233_JPD_230021
crossref_primary_10_1007_s11064_020_03187_9
crossref_primary_10_1016_j_mad_2023_111875
crossref_primary_10_1038_s41598_020_72202_4
crossref_primary_10_1016_j_arr_2021_101347
crossref_primary_10_1016_j_parkreldis_2018_11_014
crossref_primary_10_1038_s41531_016_0002_0
crossref_primary_10_1007_s13311_020_00942_2
crossref_primary_10_1111_1462_2920_14506
crossref_primary_10_1016_j_nbd_2022_105806
crossref_primary_10_3390_ijms22158022
crossref_primary_10_1016_j_neuroscience_2020_02_030
crossref_primary_10_1007_s00005_019_00561_6
crossref_primary_10_3390_biom11020144
crossref_primary_10_3389_fcimb_2023_1296713
crossref_primary_10_1186_s41983_021_00407_z
crossref_primary_10_3390_jcm9113705
crossref_primary_10_1016_j_bbi_2019_07_019
crossref_primary_10_1016_j_taap_2022_116176
crossref_primary_10_3390_nu16132041
crossref_primary_10_1016_j_jff_2023_105915
crossref_primary_10_1016_j_nutres_2022_07_007
crossref_primary_10_1177_08919887211018268
crossref_primary_10_3233_JPD_202279
crossref_primary_10_1016_j_rvsc_2024_105521
crossref_primary_10_1016_j_cbi_2021_109452
crossref_primary_10_1016_j_neuint_2018_08_005
crossref_primary_10_3233_JPD_191802
crossref_primary_10_3389_fphar_2024_1388401
crossref_primary_10_3920_BM2017_0202
crossref_primary_10_1016_j_jpsychires_2018_01_013
crossref_primary_10_1002_mds_27197
crossref_primary_10_2217_nmt_2015_0012
crossref_primary_10_1016_j_neurobiolaging_2016_08_019
crossref_primary_10_2147_CIA_S414714
crossref_primary_10_2174_1381612826666201211112846
crossref_primary_10_1007_s12640_022_00487_6
crossref_primary_10_1039_C8FO01768A
crossref_primary_10_1016_j_ebiom_2019_05_064
crossref_primary_10_14802_jmd_18067
crossref_primary_10_3390_cells9020376
crossref_primary_10_3390_cells9071687
crossref_primary_10_1016_j_bbi_2020_01_018
crossref_primary_10_1080_21678421_2021_1904994
crossref_primary_10_1186_s13024_021_00427_6
crossref_primary_10_1016_j_arr_2018_04_004
crossref_primary_10_1007_s00415_022_11461_9
crossref_primary_10_1007_s12035_024_04151_2
crossref_primary_10_3390_microorganisms11061527
crossref_primary_10_1016_j_exger_2024_112497
crossref_primary_10_1136_gutjnl_2018_316844
crossref_primary_10_1371_journal_pone_0208313
crossref_primary_10_3390_medsci9010017
crossref_primary_10_1002_mds_27304
crossref_primary_10_1016_j_tifs_2021_07_004
crossref_primary_10_1097_YPG_0000000000000255
crossref_primary_10_1093_ptj_pzac022
crossref_primary_10_1111_cns_13990
crossref_primary_10_1177_1099800418784202
crossref_primary_10_3389_fnins_2023_1225875
crossref_primary_10_1016_j_neuro_2018_02_013
crossref_primary_10_3389_fnins_2022_946601
crossref_primary_10_1016_j_nrl_2019_03_017
crossref_primary_10_3390_biology12010093
crossref_primary_10_4103_ijnpnd_ijnpnd_8_23
crossref_primary_10_3389_fneur_2018_00860
crossref_primary_10_5056_jnm17105
crossref_primary_10_3164_jcbn_18_56
crossref_primary_10_2147_JIR_S333887
crossref_primary_10_1016_j_arr_2022_101759
crossref_primary_10_1016_j_mehy_2019_109436
crossref_primary_10_1093_ibd_izy022
crossref_primary_10_3389_fnins_2019_00992
crossref_primary_10_3390_biomedicines10020436
crossref_primary_10_1038_s41531_023_00511_2
crossref_primary_10_3390_jpm12010049
crossref_primary_10_2174_1389203724666230104163924
crossref_primary_10_1016_j_chom_2020_06_008
crossref_primary_10_3233_JPD_202459
crossref_primary_10_1002_mds_27099
crossref_primary_10_1016_j_livres_2021_07_002
crossref_primary_10_18632_aging_206200
crossref_primary_10_3389_fnagi_2023_1151850
crossref_primary_10_3389_fneur_2024_1371791
crossref_primary_10_3390_nu16193384
crossref_primary_10_1099_jmm_0_001469
crossref_primary_10_3390_microorganisms11040880
crossref_primary_10_1371_journal_pone_0187307
crossref_primary_10_7554_eLife_53111
crossref_primary_10_1038_s41531_020_00145_8
crossref_primary_10_1016_j_neures_2021_01_001
crossref_primary_10_3389_fphar_2022_875349
crossref_primary_10_1186_s12866_023_02933_7
crossref_primary_10_1002_mds_27326
crossref_primary_10_3389_fnmol_2019_00218
crossref_primary_10_1016_j_phrs_2021_105840
crossref_primary_10_1007_s40473_017_0129_2
crossref_primary_10_1152_physrev_00018_2018
crossref_primary_10_1080_10408398_2022_2076064
crossref_primary_10_1124_pharmrev_122_000674
crossref_primary_10_3389_fimmu_2022_937555
crossref_primary_10_3389_fmed_2018_00053
crossref_primary_10_1016_j_bbi_2018_02_016
crossref_primary_10_1016_j_nutres_2024_11_013
crossref_primary_10_1016_j_phrs_2020_104677
crossref_primary_10_1007_s11011_021_00808_2
crossref_primary_10_1038_s41598_024_65061_w
crossref_primary_10_3389_fnint_2022_1054627
crossref_primary_10_1038_s41531_022_00328_5
crossref_primary_10_1152_ajpgi_00058_2020
crossref_primary_10_1016_j_brainres_2018_01_010
crossref_primary_10_3390_jcm10030459
crossref_primary_10_1016_j_arr_2024_102504
crossref_primary_10_1111_ejn_16667
crossref_primary_10_1055_s_0043_1771468
crossref_primary_10_3390_app142311354
crossref_primary_10_1590_0102_672020200003e1548
crossref_primary_10_3233_JPD_181493
crossref_primary_10_2174_1570159X18666200606233050
crossref_primary_10_3233_JPD_191729
crossref_primary_10_1093_brain_awab156
crossref_primary_10_1038_s41531_024_00724_z
crossref_primary_10_1016_j_nrleng_2019_03_026
crossref_primary_10_1038_s43856_024_00630_8
crossref_primary_10_1038_s41531_020_0112_6
crossref_primary_10_3389_fmed_2021_655123
crossref_primary_10_3233_JPD_212574
crossref_primary_10_3389_fnagi_2022_1026260
crossref_primary_10_3233_JPD_230206
crossref_primary_10_1007_s00415_019_09320_1
crossref_primary_10_3389_fphar_2020_00877
crossref_primary_10_3389_fneur_2020_00787
crossref_primary_10_3389_fimmu_2022_785644
crossref_primary_10_3390_biom11010030
crossref_primary_10_5056_jnm19044
crossref_primary_10_1016_j_bbi_2017_06_017
crossref_primary_10_1002_mds_27105
crossref_primary_10_3233_JPD_240244
crossref_primary_10_1093_nutrit_nuae221
crossref_primary_10_3390_cells11244038
crossref_primary_10_14336_AD_2021_0418
crossref_primary_10_1111_sji_13022
crossref_primary_10_31857_S0320972524030089
crossref_primary_10_1002_mds_27581
crossref_primary_10_1111_ejn_13869
crossref_primary_10_3390_microorganisms10071428
crossref_primary_10_3390_nu14194163
crossref_primary_10_1007_s11011_018_0239_x
crossref_primary_10_1007_s13670_018_0240_6
crossref_primary_10_1186_s12934_020_01313_4
crossref_primary_10_1016_j_brainres_2024_149032
crossref_primary_10_30629_2618_6667_2023_21_5_17_24
crossref_primary_10_1007_s00115_018_0601_6
crossref_primary_10_1186_s12974_019_1528_y
crossref_primary_10_3233_JPD_191780
crossref_primary_10_3390_ijms24119577
crossref_primary_10_12688_openreseurope_18568_1
crossref_primary_10_1371_journal_pone_0171521
crossref_primary_10_3390_biom11030433
crossref_primary_10_37349_ent_2023_00038
crossref_primary_10_1093_brain_awaa201
crossref_primary_10_3390_biom11091292
crossref_primary_10_1371_journal_pone_0217194
crossref_primary_10_1155_2021_6699268
crossref_primary_10_1007_s12602_024_10274_8
crossref_primary_10_3389_fneur_2019_01155
crossref_primary_10_1016_j_ijbiomac_2020_09_056
crossref_primary_10_3389_fneur_2021_574529
crossref_primary_10_3389_fped_2019_00394
crossref_primary_10_1016_j_tim_2022_01_004
crossref_primary_10_1038_s41583_021_00542_9
crossref_primary_10_1016_j_applanim_2022_105569
crossref_primary_10_1016_j_neubiorev_2021_02_044
crossref_primary_10_1177_09612033211050321
crossref_primary_10_1371_journal_pone_0218252
crossref_primary_10_3390_ijms20174121
crossref_primary_10_1016_j_eng_2019_07_026
crossref_primary_10_3390_nu16071066
crossref_primary_10_1016_j_toxlet_2021_12_003
crossref_primary_10_1038_s41531_024_00816_w
crossref_primary_10_1016_j_lfs_2024_122748
crossref_primary_10_1177_1877718X241312401
crossref_primary_10_1080_10408398_2020_1836605
crossref_primary_10_1172_jci_insight_92295
crossref_primary_10_2139_ssrn_4113134
crossref_primary_10_1080_1028415X_2020_1760532
crossref_primary_10_1002_mds_29300
crossref_primary_10_3390_ijms23147820
crossref_primary_10_1128_msystems_01191_21
crossref_primary_10_3389_fnagi_2020_00089
crossref_primary_10_54457_DR_202401007
crossref_primary_10_3390_brainsci12060739
crossref_primary_10_1002_med_21987
crossref_primary_10_1007_s10571_021_01066_7
crossref_primary_10_1016_j_gpb_2021_08_009
crossref_primary_10_3390_applmicrobiol3020030
crossref_primary_10_1007_s10143_021_01516_2
crossref_primary_10_2139_ssrn_3918858
crossref_primary_10_3390_ijms25126678
crossref_primary_10_3390_ijms23084148
crossref_primary_10_1186_s13024_023_00628_1
crossref_primary_10_3390_jcm10235698
crossref_primary_10_1016_j_nbd_2019_03_014
crossref_primary_10_2174_1389557522666220622111501
crossref_primary_10_1186_s12974_023_02846_2
crossref_primary_10_1002_mds_26942
crossref_primary_10_3233_JPD_230315
crossref_primary_10_3389_fnagi_2017_00441
crossref_primary_10_1128_mSystems_00797_20
crossref_primary_10_1016_j_exger_2024_112444
crossref_primary_10_14336_AD_2024_1362
crossref_primary_10_1007_s40572_018_0186_z
crossref_primary_10_1016_j_brainres_2024_148757
crossref_primary_10_1523_JNEUROSCI_1672_18_2018
crossref_primary_10_1111_ejn_14290
crossref_primary_10_3390_nu15122775
crossref_primary_10_3748_wjg_v30_i3_225
crossref_primary_10_3390_applmicrobiol3010002
crossref_primary_10_1007_s13311_017_0598_8
crossref_primary_10_3390_nu11081896
crossref_primary_10_1038_s41531_022_00428_2
crossref_primary_10_3390_antiox10111823
crossref_primary_10_1016_j_brainres_2021_147609
crossref_primary_10_1002_brb3_3130
crossref_primary_10_1007_s12035_024_04156_x
crossref_primary_10_3390_nu15153456
crossref_primary_10_3390_ijms19113573
crossref_primary_10_1111_ene_14644
crossref_primary_10_3390_nu14132661
crossref_primary_10_1155_2022_9110560
crossref_primary_10_3390_medicina59101696
crossref_primary_10_3389_fnins_2021_753915
crossref_primary_10_1016_j_jnutbio_2018_04_004
crossref_primary_10_1016_j_nbd_2020_104744
crossref_primary_10_3390_ijms232213665
crossref_primary_10_1016_j_bbi_2020_07_036
crossref_primary_10_4103_AOMD_AOMD_4_18
crossref_primary_10_1007_s10620_018_5122_4
crossref_primary_10_1016_j_brainresbull_2022_02_015
crossref_primary_10_1002_mds_28119
crossref_primary_10_3390_ijms241914582
crossref_primary_10_3390_antiox11122396
crossref_primary_10_1097_WCO_0000000000000389
crossref_primary_10_3389_fnagi_2022_881872
crossref_primary_10_3389_fneur_2019_01245
crossref_primary_10_1016_j_csbj_2022_02_024
crossref_primary_10_3389_fcimb_2021_615075
crossref_primary_10_1016_j_arr_2023_102171
crossref_primary_10_3390_ijms232012289
crossref_primary_10_1016_S1474_4422_19_30356_4
crossref_primary_10_3390_ijms252212164
crossref_primary_10_1016_j_parkreldis_2018_09_032
crossref_primary_10_1016_j_neulet_2018_12_021
crossref_primary_10_1038_s41598_020_72903_w
crossref_primary_10_14336_AD_2022_01281
crossref_primary_10_1186_s40035_019_0175_7
crossref_primary_10_3390_brainsci13081226
crossref_primary_10_1007_s10072_025_08114_w
crossref_primary_10_1038_s41598_017_10711_5
crossref_primary_10_1038_s41598_024_70960_z
crossref_primary_10_3389_fimmu_2019_00303
crossref_primary_10_3389_fimmu_2018_02067
crossref_primary_10_1016_j_brainresbull_2021_04_010
crossref_primary_10_1016_j_livres_2020_03_002
crossref_primary_10_1002_ana_24901
crossref_primary_10_1002_mds_29432
crossref_primary_10_1016_j_jbc_2022_102088
crossref_primary_10_3389_fneur_2020_01041
crossref_primary_10_1038_s41467_023_36497_x
crossref_primary_10_3233_JPD_212671
crossref_primary_10_1016_j_ajp_2024_104068
crossref_primary_10_1177_2096595820902566
crossref_primary_10_1080_10408398_2022_2128037
crossref_primary_10_1186_s40035_023_00392_8
crossref_primary_10_3389_fimmu_2020_604179
crossref_primary_10_1007_s00415_017_8639_0
crossref_primary_10_3389_fmolb_2021_770413
crossref_primary_10_1016_j_neubiorev_2020_02_003
crossref_primary_10_3390_pathogens11070796
crossref_primary_10_1515_revneuro_2022_0093
crossref_primary_10_3390_microorganisms10081544
crossref_primary_10_1016_j_cell_2016_10_027
crossref_primary_10_1016_j_biopha_2021_112343
crossref_primary_10_1271_kagakutoseibutsu_56_371
crossref_primary_10_3389_fnins_2022_1030694
crossref_primary_10_3390_nu15081815
crossref_primary_10_1002_mdc3_12840
crossref_primary_10_1016_j_fbio_2023_103548
crossref_primary_10_1111_nan_12520
crossref_primary_10_1016_j_nbd_2022_105744
crossref_primary_10_3389_fnins_2022_878239
crossref_primary_10_1016_j_nbd_2020_105027
crossref_primary_10_1016_j_neuint_2024_105803
crossref_primary_10_3390_cells8070670
crossref_primary_10_3389_fnmol_2019_00171
crossref_primary_10_3389_fmicb_2018_01417
crossref_primary_10_1159_000518147
crossref_primary_10_12938_bmfh_19_002
crossref_primary_10_1016_j_tem_2021_11_005
crossref_primary_10_3389_fcimb_2020_00098
crossref_primary_10_1210_jendso_bvz039
crossref_primary_10_3390_nu15030496
crossref_primary_10_1016_j_arr_2021_101396
crossref_primary_10_1146_annurev_pharmtox_010919_023628
crossref_primary_10_3390_ijms24087205
crossref_primary_10_1007_s00401_018_1856_5
crossref_primary_10_1136_bmjopen_2021_053336
crossref_primary_10_1371_journal_ppat_1006654
crossref_primary_10_3390_nu10060708
crossref_primary_10_4103_2045_9912_385949
crossref_primary_10_1155_ijcp_5511146
crossref_primary_10_1128_mSystems_00561_20
crossref_primary_10_1177_17590914211016217
crossref_primary_10_1177_24705470221076390
crossref_primary_10_1002_mds_28004
Cites_doi 10.1002/mds.25736
10.1016/j.bbrc.2009.06.024
10.1111/jre.12081
10.1111/j.1472-8206.2008.00616.x
10.1093/chemse/bjj037
10.1097/01.wco.0000137531.76491.c2
10.1128/AEM.01843-08
10.1007/s00415-002-1301-4
10.1186/2045-9912-2-15
10.1172/JCI111738
10.1016/j.parkreldis.2014.12.009
10.1016/j.freeradbiomed.2009.11.026
10.1128/IAI.69.11.6942-6950.2001
10.1515/CCLM.1999.047
10.1371/journal.pone.0007247
10.1016/j.nbd.2012.09.007
10.1172/JCI109836
10.1111/j.1572-0241.2005.40312.x
10.1007/s10620-012-2526-4
10.1212/01.wnl.0000247740.47667.03
10.1371/journal.pone.0028032
10.1084/jem.164.3.777
10.1016/S0026-0495(97)90136-0
10.1159/000103892
10.1016/0165-1838(95)00002-F
10.1093/infdis/171.5.1250
10.1016/j.neulet.2009.02.016
10.1128/JCM.01724-09
10.2337/dc13-2817
10.1002/mds.23566
10.1093/brain/awt192
10.1016/j.parkreldis.2009.08.007
10.1002/mds.25375
10.1111/j.1447-0594.2010.00585.x
10.1002/mds.25522
10.1002/mds.26069
10.1016/j.parkreldis.2014.02.019
10.1126/science.1241214
10.1212/WNL.57.3.456
10.1212/01.wnl.0000221672.01272.ba
10.1172/JCI116106
10.1016/S0197-4580(02)00065-9
10.1021/cr050196r
10.1128/AEM.01224-06
10.1002/mds.23838
10.1038/nature12820
ContentType Journal Article
Copyright 2015 Hasegawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2015 Hasegawa et al 2015 Hasegawa et al
Copyright_xml – notice: 2015 Hasegawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2015 Hasegawa et al 2015 Hasegawa et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0142164
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Agricultural Science Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Intestinal Dysbiosis in PD
EISSN 1932-6203
EndPage e0142164
ExternalDocumentID 1730684030
oai_doaj_org_article_84d170aedc5f4cdbb3ba8db46a293389
PMC4634857
3858341881
26539989
10_1371_journal_pone_0142164
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PJZUB
PPXIY
PQGLB
RIG
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
BBORY
KM
ID FETCH-LOGICAL-c592t-870fa4071ccccd30adc70be5f6fd9d77a2d4e0af3415b1573280d55e32fe55353
IEDL.DBID DOA
ISSN 1932-6203
IngestDate Fri Nov 26 17:12:29 EST 2021
Wed Aug 27 01:31:54 EDT 2025
Thu Aug 21 18:31:11 EDT 2025
Fri Jul 11 11:34:55 EDT 2025
Fri Jul 25 10:22:32 EDT 2025
Mon Jul 21 06:02:43 EDT 2025
Thu Apr 24 22:58:13 EDT 2025
Tue Jul 01 03:55:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c592t-870fa4071ccccd30adc70be5f6fd9d77a2d4e0af3415b1573280d55e32fe55353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: MH KO KN. Performed the experiments: HT TA SH. Analyzed the data: TO AS. Contributed reagents/materials/analysis tools: SH SG YF TM. Wrote the paper: SH KO MH. Prediction of hydrogen-producing bacteria: SH AO.
Competing Interests: The study was funded by Yakult Central Institute. HT, TA, and KN are employed by the Yakult Central Institute. HT, TA, and KN blindly analyzed fecal samples. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The other authors have no competing interests.
OpenAccessLink https://doaj.org/article/84d170aedc5f4cdbb3ba8db46a293389
PMID 26539989
PQID 1730684030
PQPubID 1436336
ParticipantIDs plos_journals_1730684030
doaj_primary_oai_doaj_org_article_84d170aedc5f4cdbb3ba8db46a293389
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4634857
proquest_miscellaneous_1731783821
proquest_journals_1730684030
pubmed_primary_26539989
crossref_citationtrail_10_1371_journal_pone_0142164
crossref_primary_10_1371_journal_pone_0142164
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-11-05
PublicationDateYYYYMMDD 2015-11-05
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-11-05
  day: 05
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2015
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References DA Drossman (ref14) 2006; 15
K Matsuda (ref18) 2009; 75
VK Ridaura (ref9) 2013; 341
D Devos (ref29) 2013; 50
A Keshavarzian (ref11) 2015
S Sakaguchi (ref19) 2010; 48
CH Hawkes (ref3) 2010; 16
M Kobayashi (ref13) 2006; 31
A Gasbarrini (ref33) 2007; 25
RC Seet (ref52) 2010; 48
PM Vignais (ref25) 2007; 107
JH Kordower (ref26) 2013; 136
M Kajiya (ref44) 2009; 386
M Gabrielli (ref34) 2011; 26
ref41
Y Fu (ref22) 2009; 453
AH Tan (ref36) 2014; 20
B Baranowska (ref39) 1997; 46
KM Shannon (ref28) 2012; 27
J Sato (ref21) 2014; 37
TR Martin (ref49) 1992; 90
H Braak (ref27) 2002; 249
R Katzenschlager (ref4) 2004; 17
LP Kelly (ref31) 2014; 29
SM Goldman (ref30) 2014
AH Froon (ref47) 1995; 171
M Pierantozzi (ref37) 2006; 66
LA David (ref40) 2014; 505
AH Tan (ref38) 2015; 21
S Ohigashi (ref20) 2013; 58
K Matsuda (ref17) 2007; 73
C Florent (ref45) 1985; 75
E Malinen (ref42) 2005; 100
M Ito (ref43) 2012; 2
ER Dorsey (ref1) 2007; 68
PS Tobias (ref46) 1986; 164
PH Ding (ref50) 2014; 49
F Scheperjans (ref10) 2015; 30
GD Luk (ref16) 1980; 66
G Dutta (ref32) 2008; 22
A Yoritaka (ref24) 2013; 28
Y Fujiwara (ref12) 2010; 10
H Braak (ref2) 2003; 24
RD Abbott (ref6) 2001; 57
T Mitsuoka (ref8) 1996; 5
N Dzamko (ref51) 2014
M Hirayama (ref5) 1995; 53
K Fujita (ref23) 2009; 4
CB Forsyth (ref7) 2011; 6
RR Schumann (ref48) 1999; 37
A Fasano (ref35) 2013; 28
T Gutsmann (ref15) 2001; 69
24394457 - Asia Pac J Clin Nutr. 1996 Mar;5(1):2-9
12498954 - Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
3973020 - J Clin Invest. 1985 Feb;75(2):608-13
22145021 - PLoS One. 2011;6(12):e28032
24838182 - Mov Disord. 2014 Aug;29(9):1171-80
24637123 - Parkinsonism Relat Disord. 2014 May;20(5):535-40
23306850 - Dig Dis Sci. 2013 Jun;58(6):1717-26
20351213 - J Clin Microbiol. 2010 May;48(5):1624-8
7560760 - J Auton Nerv Syst. 1995 Jun 25;53(2-3):230-4
26179554 - Mov Disord. 2015 Sep;30(10):1351-60
15247536 - Curr Opin Neurol. 2004 Aug;17(4):417-23
17082464 - Neurology. 2007 Jan 30;68(5):384-6
23017648 - Neurobiol Dis. 2013 Feb;50:42-8
19356598 - Neurosci Lett. 2009 Apr 3;453(2):81-5
24898698 - Mov Disord. 2014 Jul;29(8):999-1009
19523450 - Biochem Biophys Res Commun. 2009 Aug 21;386(2):316-21
16801644 - Neurology. 2006 Jun 27;66(12):1824-9
24009397 - Science. 2013 Sep 6;341(6150):1241214
22608009 - Med Gas Res. 2012 May 20;2(1):15
20141536 - Geriatr Gerontol Int. 2010 Jul;10(3):225-32
19969070 - Free Radic Biol Med. 2010 Feb 15;48(4):560-6
11502913 - Neurology. 2001 Aug 14;57(3):456-62
21520278 - Mov Disord. 2011 Apr;26(5):889-92
6772669 - J Clin Invest. 1980 Jul;66(1):66-70
25560322 - Parkinsonism Relat Disord. 2015 Mar;21(3):221-5
15667495 - Am J Gastroenterol. 2005 Feb;100(2):373-82
24824547 - Diabetes Care. 2014 Aug;37(8):2343-50
11598069 - Infect Immun. 2001 Nov;69(11):6942-50
9439531 - Metabolism. 1997 Dec;46(12):1384-9
25450953 - Neuroscience. 2015 Aug 27;302:89-102
17927159 - Chem Rev. 2007 Oct;107(10):4206-72
19201979 - Appl Environ Microbiol. 2009 Apr;75(7):1961-9
17013448 - J Gastrointestin Liver Dis. 2006 Sep;15(3):237-41
17071791 - Appl Environ Microbiol. 2007 Jan;73(1):32-9
24336217 - Nature. 2014 Jan 23;505(7484):559-63
23884810 - Brain. 2013 Aug;136(Pt 8):2419-31
16495437 - Chem Senses. 2006 May;31(4):335-42
19789628 - PLoS One. 2009;4(9):e7247
19846332 - Parkinsonism Relat Disord. 2010 Feb;16(2):79-84
1281827 - J Clin Invest. 1992 Dec;90(6):2209-19
17827947 - Dig Dis. 2007;25(3):237-40
23400965 - Mov Disord. 2013 Jun;28(6):836-9
21766334 - Mov Disord. 2012 May;27(6):709-15
18710400 - Fundam Clin Pharmacol. 2008 Oct;22(5):453-64
25476529 - Mov Disord. 2015 Mar;30(3):350-8
23601005 - J Periodontal Res. 2014 Feb;49(1):1-9
7538550 - J Infect Dis. 1995 May;171(5):1250-7
23712625 - Mov Disord. 2013 Aug;28(9):1241-9
12528692 - J Neurol. 2002 Oct;249 Suppl 3:III/1-5
2427635 - J Exp Med. 1986 Sep 1;164(3):777-93
10353471 - Clin Chem Lab Med. 1999 Mar;37(3):271-4
References_xml – volume: 29
  start-page: 999
  issue: 8
  year: 2014
  ident: ref31
  article-title: Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.25736
– volume: 386
  start-page: 316
  issue: 2
  year: 2009
  ident: ref44
  article-title: Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2009.06.024
– volume: 49
  start-page: 1
  issue: 1
  year: 2014
  ident: ref50
  article-title: The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health
  publication-title: J Periodontal Res
  doi: 10.1111/jre.12081
– year: 2014
  ident: ref30
  article-title: Peptidoglycan recognition protein genes and risk of Parkinson's disease
  publication-title: Mov Disord
– volume: 22
  start-page: 453
  issue: 5
  year: 2008
  ident: ref32
  article-title: The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2008.00616.x
– volume: 31
  start-page: 335
  issue: 4
  year: 2006
  ident: ref13
  article-title: Cross-cultural comparison of data using the odor stick identification test for Japanese (OSIT-J)
  publication-title: Chem Senses
  doi: 10.1093/chemse/bjj037
– volume: 17
  start-page: 417
  issue: 4
  year: 2004
  ident: ref4
  article-title: Olfaction and Parkinson's syndromes: its role in differential diagnosis
  publication-title: Curr Opin Neurol
  doi: 10.1097/01.wco.0000137531.76491.c2
– volume: 75
  start-page: 1961
  issue: 7
  year: 2009
  ident: ref18
  article-title: Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.01843-08
– volume: 249
  start-page: III/1
  issue: Suppl 3
  year: 2002
  ident: ref27
  article-title: Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)
  publication-title: J Neurol
  doi: 10.1007/s00415-002-1301-4
– volume: 2
  start-page: 15
  issue: 1
  year: 2012
  ident: ref43
  article-title: Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats
  publication-title: Med Gas Res
  doi: 10.1186/2045-9912-2-15
– year: 2015
  ident: ref11
  article-title: Colonic bacterial composition in Parkinson's disease
  publication-title: Mov Disord
– volume: 75
  start-page: 608
  issue: 2
  year: 1985
  ident: ref45
  article-title: Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study)
  publication-title: J Clin Invest
  doi: 10.1172/JCI111738
– volume: 21
  start-page: 221
  issue: 3
  year: 2015
  ident: ref38
  article-title: Helicobacter pylori infection is associated with worse severity of Parkinson's disease
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2014.12.009
– volume: 48
  start-page: 560
  issue: 4
  year: 2010
  ident: ref52
  article-title: Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2009.11.026
– volume: 69
  start-page: 6942
  issue: 11
  year: 2001
  ident: ref15
  article-title: Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells
  publication-title: Infect Immun
  doi: 10.1128/IAI.69.11.6942-6950.2001
– volume: 37
  start-page: 271
  issue: 3
  year: 1999
  ident: ref48
  article-title: A novel acute-phase marker: lipopolysaccharide binding protein (LBP)
  publication-title: Clinf Chem Lab Med
  doi: 10.1515/CCLM.1999.047
– volume: 4
  start-page: e7247
  issue: 9
  year: 2009
  ident: ref23
  article-title: Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0007247
– volume: 50
  start-page: 42
  year: 2013
  ident: ref29
  article-title: Colonic inflammation in Parkinson's disease
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2012.09.007
– volume: 66
  start-page: 66
  issue: 1
  year: 1980
  ident: ref16
  article-title: Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity
  publication-title: J Clin Invest
  doi: 10.1172/JCI109836
– year: 2014
  ident: ref51
  article-title: Inflammation is genetically implicated in Parkinson's disease
  publication-title: Neuroscience
– volume: 100
  start-page: 373
  issue: 2
  year: 2005
  ident: ref42
  article-title: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2005.40312.x
– volume: 58
  start-page: 1717
  issue: 6
  year: 2013
  ident: ref20
  article-title: Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-012-2526-4
– volume: 68
  start-page: 384
  issue: 5
  year: 2007
  ident: ref1
  article-title: Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000247740.47667.03
– volume: 6
  start-page: e28032
  issue: 12
  year: 2011
  ident: ref7
  article-title: Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0028032
– volume: 164
  start-page: 777
  issue: 3
  year: 1986
  ident: ref46
  article-title: Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum
  publication-title: J Exp Med
  doi: 10.1084/jem.164.3.777
– volume: 46
  start-page: 1384
  issue: 12
  year: 1997
  ident: ref39
  article-title: Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa
  publication-title: Metabolism
  doi: 10.1016/S0026-0495(97)90136-0
– volume: 25
  start-page: 237
  issue: 3
  year: 2007
  ident: ref33
  article-title: Small intestinal bacterial overgrowth: diagnosis and treatment
  publication-title: Dig Dis
  doi: 10.1159/000103892
– volume: 53
  start-page: 230
  issue: 2–3
  year: 1995
  ident: ref5
  article-title: A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure
  publication-title: J Auton Nerv Syst
  doi: 10.1016/0165-1838(95)00002-F
– volume: 171
  start-page: 1250
  issue: 5
  year: 1995
  ident: ref47
  article-title: Lipopolysaccharide toxicity-regulating proteins in bacteremia
  publication-title: J Infect Dis
  doi: 10.1093/infdis/171.5.1250
– volume: 453
  start-page: 81
  issue: 2
  year: 2009
  ident: ref22
  article-title: Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2009.02.016
– volume: 48
  start-page: 1624
  issue: 5
  year: 2010
  ident: ref19
  article-title: Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01724-09
– volume: 37
  start-page: 2343
  issue: 8
  year: 2014
  ident: ref21
  article-title: Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc13-2817
– volume: 26
  start-page: 889
  issue: 5
  year: 2011
  ident: ref34
  article-title: Prevalence of small intestinal bacterial overgrowth in Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.23566
– ident: ref41
– volume: 136
  start-page: 2419
  issue: Pt 8
  year: 2013
  ident: ref26
  article-title: Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
  publication-title: Brain
  doi: 10.1093/brain/awt192
– volume: 16
  start-page: 79
  issue: 2
  year: 2010
  ident: ref3
  article-title: A timeline for Parkinson's disease
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2009.08.007
– volume: 28
  start-page: 836
  issue: 6
  year: 2013
  ident: ref24
  article-title: Pilot study of H2 therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial
  publication-title: Mov Disord
  doi: 10.1002/mds.25375
– volume: 10
  start-page: 225
  issue: 3
  year: 2010
  ident: ref12
  article-title: Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment
  publication-title: Geriatr Gerontol Int
  doi: 10.1111/j.1447-0594.2010.00585.x
– volume: 28
  start-page: 1241
  issue: 9
  year: 2013
  ident: ref35
  article-title: The role of small intestinal bacterial overgrowth in Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.25522
– volume: 30
  start-page: 350
  issue: 3
  year: 2015
  ident: ref10
  article-title: Gut microbiota are related to Parkinson's disease and clinical phenotype
  publication-title: Mov Disord
  doi: 10.1002/mds.26069
– volume: 20
  start-page: 535
  issue: 5
  year: 2014
  ident: ref36
  article-title: Small intestinal bacterial overgrowth in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2014.02.019
– volume: 341
  start-page: 1241214
  issue: 6150
  year: 2013
  ident: ref9
  article-title: Gut microbiota from twins discordant for obesity modulate metabolism in mice
  publication-title: Science
  doi: 10.1126/science.1241214
– volume: 57
  start-page: 456
  issue: 3
  year: 2001
  ident: ref6
  article-title: Frequency of bowel movements and the future risk of Parkinson's disease
  publication-title: Neurology
  doi: 10.1212/WNL.57.3.456
– volume: 15
  start-page: 237
  issue: 3
  year: 2006
  ident: ref14
  article-title: Rome III: New standard for functional gastrointestinal disorders
  publication-title: J Gastrointestin Liver Dis
– volume: 66
  start-page: 1824
  issue: 12
  year: 2006
  ident: ref37
  article-title: Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000221672.01272.ba
– volume: 90
  start-page: 2209
  issue: 6
  year: 1992
  ident: ref49
  article-title: Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs
  publication-title: J Clin Invest
  doi: 10.1172/JCI116106
– volume: 24
  start-page: 197
  issue: 2
  year: 2003
  ident: ref2
  article-title: Staging of brain pathology related to sporadic Parkinson's disease
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(02)00065-9
– volume: 107
  start-page: 4206
  issue: 10
  year: 2007
  ident: ref25
  article-title: Occurrence, classification, and biological function of hydrogenases: an overview
  publication-title: Chem Rev
  doi: 10.1021/cr050196r
– volume: 73
  start-page: 32
  issue: 1
  year: 2007
  ident: ref17
  article-title: Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.01224-06
– volume: 5
  start-page: 2
  issue: 1
  year: 1996
  ident: ref8
  article-title: Intestinal flora and human health
  publication-title: Asia Pac J Clin Nutr
– volume: 27
  start-page: 709
  issue: 6
  year: 2012
  ident: ref28
  article-title: Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.23838
– volume: 505
  start-page: 559
  issue: 7484
  year: 2014
  ident: ref40
  article-title: Diet rapidly and reproducibly alters the human gut microbiome
  publication-title: Nature
  doi: 10.1038/nature12820
– reference: 1281827 - J Clin Invest. 1992 Dec;90(6):2209-19
– reference: 17927159 - Chem Rev. 2007 Oct;107(10):4206-72
– reference: 20351213 - J Clin Microbiol. 2010 May;48(5):1624-8
– reference: 23306850 - Dig Dis Sci. 2013 Jun;58(6):1717-26
– reference: 19356598 - Neurosci Lett. 2009 Apr 3;453(2):81-5
– reference: 23601005 - J Periodontal Res. 2014 Feb;49(1):1-9
– reference: 3973020 - J Clin Invest. 1985 Feb;75(2):608-13
– reference: 2427635 - J Exp Med. 1986 Sep 1;164(3):777-93
– reference: 23400965 - Mov Disord. 2013 Jun;28(6):836-9
– reference: 21520278 - Mov Disord. 2011 Apr;26(5):889-92
– reference: 12528692 - J Neurol. 2002 Oct;249 Suppl 3:III/1-5
– reference: 23884810 - Brain. 2013 Aug;136(Pt 8):2419-31
– reference: 11502913 - Neurology. 2001 Aug 14;57(3):456-62
– reference: 16495437 - Chem Senses. 2006 May;31(4):335-42
– reference: 24394457 - Asia Pac J Clin Nutr. 1996 Mar;5(1):2-9
– reference: 17013448 - J Gastrointestin Liver Dis. 2006 Sep;15(3):237-41
– reference: 22608009 - Med Gas Res. 2012 May 20;2(1):15
– reference: 7538550 - J Infect Dis. 1995 May;171(5):1250-7
– reference: 23712625 - Mov Disord. 2013 Aug;28(9):1241-9
– reference: 19201979 - Appl Environ Microbiol. 2009 Apr;75(7):1961-9
– reference: 20141536 - Geriatr Gerontol Int. 2010 Jul;10(3):225-32
– reference: 16801644 - Neurology. 2006 Jun 27;66(12):1824-9
– reference: 24824547 - Diabetes Care. 2014 Aug;37(8):2343-50
– reference: 9439531 - Metabolism. 1997 Dec;46(12):1384-9
– reference: 7560760 - J Auton Nerv Syst. 1995 Jun 25;53(2-3):230-4
– reference: 21766334 - Mov Disord. 2012 May;27(6):709-15
– reference: 25450953 - Neuroscience. 2015 Aug 27;302:89-102
– reference: 18710400 - Fundam Clin Pharmacol. 2008 Oct;22(5):453-64
– reference: 24838182 - Mov Disord. 2014 Aug;29(9):1171-80
– reference: 17827947 - Dig Dis. 2007;25(3):237-40
– reference: 19523450 - Biochem Biophys Res Commun. 2009 Aug 21;386(2):316-21
– reference: 26179554 - Mov Disord. 2015 Sep;30(10):1351-60
– reference: 22145021 - PLoS One. 2011;6(12):e28032
– reference: 24009397 - Science. 2013 Sep 6;341(6150):1241214
– reference: 17082464 - Neurology. 2007 Jan 30;68(5):384-6
– reference: 19789628 - PLoS One. 2009;4(9):e7247
– reference: 11598069 - Infect Immun. 2001 Nov;69(11):6942-50
– reference: 15247536 - Curr Opin Neurol. 2004 Aug;17(4):417-23
– reference: 19846332 - Parkinsonism Relat Disord. 2010 Feb;16(2):79-84
– reference: 15667495 - Am J Gastroenterol. 2005 Feb;100(2):373-82
– reference: 24898698 - Mov Disord. 2014 Jul;29(8):999-1009
– reference: 19969070 - Free Radic Biol Med. 2010 Feb 15;48(4):560-6
– reference: 25560322 - Parkinsonism Relat Disord. 2015 Mar;21(3):221-5
– reference: 6772669 - J Clin Invest. 1980 Jul;66(1):66-70
– reference: 23017648 - Neurobiol Dis. 2013 Feb;50:42-8
– reference: 24336217 - Nature. 2014 Jan 23;505(7484):559-63
– reference: 17071791 - Appl Environ Microbiol. 2007 Jan;73(1):32-9
– reference: 25476529 - Mov Disord. 2015 Mar;30(3):350-8
– reference: 12498954 - Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
– reference: 24637123 - Parkinsonism Relat Disord. 2014 May;20(5):535-40
– reference: 10353471 - Clin Chem Lab Med. 1999 Mar;37(3):271-4
SSID ssj0053866
Score 2.6194956
Snippet The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and α-synuclein in the...
Background The intestine is one of the first affected organs in Parkinson’s disease (PD). PD subjects show abnormal staining for Escherichia coli and...
BACKGROUNDThe intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and...
Background The intestine is one of the first affected organs in Parkinson’s disease (PD). PD subjects show abnormal staining for Escherichia coli and...
SourceID plos
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0142164
SubjectTerms Acute-Phase Proteins
Aged
Bacteria
Bacteria - genetics
Bacteroides fragilis
Cancer
Carrier Proteins - blood
Case-Control Studies
Clostridium
Colon
Constipation
Constipation - blood
Constipation - microbiology
DNA, Bacterial - genetics
Dysbacteriosis
Dysbiosis - blood
Dysbiosis - microbiology
E coli
Feces - microbiology
Female
Gene sequencing
Helicobacter pylori
Humans
Hydrogen
Intestinal Mucosa - microbiology
Intestine
Irritable bowel syndrome
Laboratories
Lactobacillus
Lipopolysaccharide-binding protein
Lipopolysaccharides
Male
Membrane Glycoproteins - blood
Membrane permeability
Metabolism
Metagenome - genetics
Microbiota
Movement disorders
Mucosa
Nervous system
Neurodegenerative diseases
Organs
Oxidative stress
Parkinson Disease - blood
Parkinson Disease - microbiology
Parkinson's disease
Parkinsons disease
Patients
Permeability
Polymerase chain reaction
Proteins
Regression analysis
Regression models
RNA, Ribosomal, 16S - genetics
rRNA 16S
rRNA 23S
Synuclein
University graduates
Womens health
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXLggyquhBRmJAxzSJvEre0KUUlWoIA5U2lvkV2ikkiz17qG3_g3-Hr-EGccbWFRBlFPsxI5nxjNje74h5KU2yhlrPbglM51z0Om5UaXJGYYjaMY1jzizHz_JkzP-YS7macEtpGOV6zkxTtRusLhGflAqfJ0DT75ZfM8xaxTurqYUGrfJHYQuwyNdaj45XCDLUqZwOabKg0Sd_cXQ-31wDapS8g11FFH7EeX0Ygg3WZx_H5z8QxMd3yf3kglJ34403ya3fP-AbCchDfRVQpJ-_ZAYXO8DGcbqR1fBdEPoAtW9o6eYHM07ClPF6hs97RaYK-EqaItRWJ3z-WEXw13oZ8Rx6HoKNwZIx1ixn9c_Aj0ad3YekbPj91_eneQpqUJuxaxawuxXtBq9OAuXY4V2VhXGi1a2buaU0pXjvtAtaDdhSoFYPoUTwrOq9UIwwR6TrR4GcIdQUHq19wWH7zFeO2VMy63UwhfeiVr6jLD12DY2IY5j4ouLJm6jKfA8xhFrkCJNokhG8umtxYi48Z_6h0i2qS7iZccHw-XXJolfU3NXqkID5QT00RnDjK6d4VKDuQM2W0Z2kOjrBkLzm90ysrdmhJuLX0zFIJm43aJ7P6xinVLVrK7KjDwZ-WbqZBURgbFdtcFRG3-xWdJ35xH9m0sYbKGe_rtbu-QumHYiRk2KPbK1vFz5Z2A-Lc3zKCO_AB4uH9E
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKuXBBtDwaKJWRkIBDVklsx9kDQn1QVahFHFipt2DHDkRakmW9K7H_nhnHiVi0iAtRTrEdJ_PwzMSZbwh5qbQ0uqoshCVTFXOw6bGWqY4ZpiMoxhX3OLM3H_OrGf9wK273yFCzNRDQ7QztsJ7UbDmf_PyxeQcK_9ZXbZDpMGiy6Fo7AZc_gxDgDrkLtkmiqt7wcV8BtDvPQwLd30ZuGSiP44-4p_PO7fJB__yV8jfbdPmA3A9OJT3tpeCA7Nn2kBwEtXX0dcCWfvOQfMEvgKDV2P1i43TTucZR1Rp6jeXSrKGweKy_0-tmgdUTNk5VmJfVGBufNT4Bhn5CZIempXBiyrTPHnvl6EW_0_OIzC7ffz6_ikORhbgS02wFq2FSK4zqKjgMS5SpZKKtqPPaTI2UKjPcJqoGayd0KhDbJzFCWJbVVggm2GOy3wL5jggFI1hYm3C4H-OFkVrXvMqVsIk1oshtRNhA2bIKCORYCGNe-m01CZFIT68S-VEGfkQkHkctegSOf_Q_Q6aNfRE_21_oll_LoI5lwU0qEwV8E_CMRmumVWE0zxW4P-DDReQIWT5M4MpUovRyWBIjcjyIwe7mF2MzaCpuv6jWdmvfJ5UFK7I0Ik96qRkfMvMIwTiv3JKnrbfYbmmbbx4NnOdAbCGf_o_XfkbugUMofK6lOCb7q-XaPgena6VPvB79AkY7MXQ
  priority: 102
  providerName: Scholars Portal
Title Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/26539989
https://www.proquest.com/docview/1730684030
https://www.proquest.com/docview/1731783821
https://pubmed.ncbi.nlm.nih.gov/PMC4634857
https://doaj.org/article/84d170aedc5f4cdbb3ba8db46a293389
http://dx.doi.org/10.1371/journal.pone.0142164
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT9swFLc2dtllgn0RYJUnTdp2CMTxZ48rtKAJEJqG1Ftmx44WiaUVaQ9c9rfvPSet6ITEhSjyIXa-3qdfnPd7hHyyTntXlgHCkqFNBfj01GnmUo7pCJYLKyLO7MWlOrsW36dyeq_UF_4T1sEDd4Q7MsIzndngS1mJ0jvHnTXeCWXBUYG3ResLPm8VTHU2GLRYqT5Rjmt21PPlcD5rwiEEBTlTYsMRRbx-xDe9mbUPzTX__2Xyng-abJNX_eSRfuseeoc8C81rstOrZ0u_9BjSX9-QX_ilD7QXh5_cta6etXVLbePpOZZFC56CkVj-oef1HKsk3LW2xPyr2od0VMdEF3qFCA51Q2HH1OiYJfa5pSfdis5bcj0Z_zw-S_tiCmkph_kCrF5WWYzeStg8z6wvdeaCrFTlh15rm3sRMluBV5OOScTwybyUgedVkJJL_o5sNUC-XULB2ZkQMgHX48J47RxwRlkZsuClUSEhfEXZouyRxrHgxU0Rl880RBwdvQrkR9HzIyHp-qx5h7TxyPgRMm09FnGy4wGQnqKXnuIx6UnILrJ8dYO2YBqlVIDpS8jBSgwe7v647gaNxGUW24TZMo5h2nCTs4S876Rm_ZB5RALG--oNedp4i82epv4dUb-FAmJLvfcUr71PXsLET8acSnlAtha3y_ABJlcLNyDP9VRDa44ZtpPTAXkxGl9e_RhEDYP2Qhhs_47_ARMlLf8
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB5V5QAXRPlraAEjgQSHtPmx4-wBIcpSbem24tBKewt27JRIJdk2u0J74zV4CR6KJ2HGSRYWVXDqKqe1kzjzP3HmG4DnSkuj89xiWjJQPkef7msZaj-mcgQVc8UdzuzRcTI65R8mYrIGP_paGPqssreJzlCbOqd35LuhpNM5yuSb6YVPXaNod7VvodGKxaFdfMWUrXl9MET-voii_fcn70Z-11XAz8UgmqH6B4WiNCbHn4kDZXIZaCuKpDADI6WKDLeBKtC8Cx0KArMJjBA2jgorhOsSgSb_BjregDRKTpYJHtqOJOnK82IZ7nbSsDOtK7uDqUgUJnzF_bkuAYSqel43V0W4f3-o-Yfn278Dt7uQlb1tZWwD1mx1FzY6o9Cwlx1y9at7oOn9ItoMmj5cNLqsm7JhqjJsTM3YrGFomuZf2LicUm-GRaNyqvoqjfX3Sldewz4SbkRZMTyoINvVpv389r1hw3Yn6T6cXgu5H8B6hQTcBIZONrU24Hi9mKdGal3wPFHCBtaINLEexD1ts7xDOKdGG-eZ27aTmOm0FMuII1nHEQ_85VnTFuHjP_P3iG3LuYTP7f6oL8-yTt2zlJtQBgo5J3CNRutYq9RonigMrzBG9GCTmN7foMl-i7cH270gXD38bDmMloC2d1Rl67mbE8o0TqPQg4et3CwXGTkEYrqvXJGoladYHanKzw5tnCdIbCEf_XtZT-Hm6ORonI0Pjg-34BaGlcJVbIptWJ9dzu1jDN1m-onTFwafrltBfwE19F0a
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemTUK8IMa_BQYYCSR4yJrEdpw-IMQo1cbKtAcm9S3YsQORRtItrVDf-Bp8FT4On4Q7xykUTfC0qk-10zh355_vYt_vCHmqtDS6KCyEJUMVcljTQy1jHTJMR1CMK-54Zt8fpwen_N1UTDfIjz4XBo9V9pjogNo0Bb4jH8QSL-dgk4PSH4s4GY1fzc5DrCCFO619OY3ORI7s8iuEb-3LwxHo-lmSjN9-eHMQ-goDYSGGyRygICoVhjQFfAyLlClkpK0o09IMjZQqMdxGqgSoFzoWSGwTGSEsS0orhKsYAfC_JZmIcY7J6SrYAxxJU5-qx2Q88JaxN2tquwdhSRKnfG0pdBUDkGH1rGkv83b_PrT5xyo4vkluePeVvu7sbZts2PoW2fYA0dLnnsX6xW2i8V0j4Ad2Hy1bXTVt1VJVGzrBwmzWUICpxRc6qWZYp2HZqgIzwCpjw_3KpdrQE-SQqGoKX0zOdnlqP799b-mo21W6Q06vRNx3yWYNAtwhFBbczNqIw_8xnhmpdcmLVAkbWSOy1AaE9bLNC892jkU3znK3hSch6ukklqNGcq-RgISrq2Yd28d_-u-j2lZ9kavb_dBcfMr91M8zbmIZKdCcgDEarZlWmdE8VeBqgb8YkB1Uen-DNv9t6gHZ7Q3h8uYnq2ZABdzqUbVtFq5PLDOWJXFA7nV2sxpk4tiI8b5yzaLWnmK9pa4-O-ZxnoKwhbz_72E9JtdgauaTw-OjB-Q6eJjCJW-KXbI5v1jYh-DFzfUjN10o-XjV8_MXHW1hUA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intestinal+Dysbiosis+and+Lowered+Serum+Lipopolysaccharide-Binding+Protein+in+Parkinson%27s+Disease&rft.jtitle=PloS+one&rft.au=Satoru+Hasegawa&rft.au=Sae+Goto&rft.au=Hirokazu+Tsuji&rft.au=Tatsuya+Okuno&rft.date=2015-11-05&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=10&rft.issue=11&rft.spage=e0142164&rft_id=info:doi/10.1371%2Fjournal.pone.0142164&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_84d170aedc5f4cdbb3ba8db46a293389
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon